logo
Meta finalises investment in Scale AI, valuing startup at $29 billion

Meta finalises investment in Scale AI, valuing startup at $29 billion

Time of India2 days ago

Synopsis
Meta has finalised an investment of $14.3 billion in Scale AI, valuing the startup at over $29 billion. Scale CEO Alexandr Wang will join Meta's new AGI-focused unit, with Jason Droege as interim CEO. The deal, Meta's second-largest ever, strengthens its AI ambitions and offers insights into rival labs' data strategies.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Meta's data broker
Meta's data broker

The Hindu

time4 hours ago

  • The Hindu

Meta's data broker

Alexandr Wang, a 28-year-old entrepreneur, has emerged as a key player in the rapidly evolving landscape of artificial intelligence. His company, Scale AI, has strategically positioned itself at the forefront of this transformation. Founded in 2016 as a data labelling company for autonomous vehicles, Scale AI quickly gained prominence. It secured partnerships with major tech giants such as OpenAI, Microsoft, Nvidia, and even the U.S. government. In a significant development, Meta Platforms has invested $14.3 billion to acquire a 49% stake in Scale AI. This acquisition marks a pivotal moment for the company, which now specialises in data curation and intelligent dataset management. As part of this deal, Mr. Alexandr is expected to assume a leadership role within Meta, leading the company's new 'superintelligence' research lab. This move is a much-needed talent refresh and reputation boost for Meta, which has been losing AI researchers and struggling with its Llama 4 launch. The company is bleeding AI talent as researchers are leaving for rival French startup Mistral. Meta's investment in AI is a significant move, and it aligns with the strategies employed by other tech giants. For instance, Microsoft has backed OpenAI, while Amazon supports Anthropic. These partnerships highlight the crucial role of specialised AI firms in the broader ecosystem. However, the Meta-Scale AI deal has sparked discussions about its implications. Some believe it represents an 'exit' for Scale AI, potentially impacting its ability to serve Meta's competitors like Google and OpenAI. Others question whether it's a strategic partnership to enhance Scale AI's capabilities while bolstering Meta's AI standing, or if it's a talent acquisition move by Meta. The deal's structure, with Mr. Alexandr reportedly retaining voting control over Scale despite his move to Meta, indicates a complex arrangement aimed at balancing these interests. Regardless, this move underscores Meta's commitment to leading the AI race. Mr. Alexandr, a vocal advocate for the strategic importance of AI for the U.S. as a matter of national security, was shaped by his upbringing in Los Alamos, New Mexico, the birthplace of the atomic bomb. In a TED Talk, he drew parallels between the transformative impact of the atomic bomb on past warfare and the current potential of AI to redefine global power. AI arms race Mr. Alexandr asserts that, as seen in the Second World War with the atomic bomb, the country that rapidly and effectively integrates new technology into warfare emerges victorious. He warns that the U.S. risks falling behind in the AI arms race, particularly against China, which he claims is ahead in accumulating the vast datasets necessary to develop powerful AI models. Mr. Alexandr has urged the U.S. government to establish a national data reserve, treating data as a strategic national resource akin to petroleum. Scale AI has actively pursued defence contracts, collaborating with the U.S. Department of Defense, Air Force, and the Army to test and evaluate large language models for military purposes. Mr. Alexandr views this work as a 'moral imperative', especially after witnessing China's advances in AI for surveillance and military applications. Mr. Alexandr predicts that AI will dominate warfare within the next decade. He emphasises that 'data will become a new kind of ammunition in the era of AI warfare'. This underscores his call for robust investment in data infrastructure, not only for military superiority but also as a deterrent, akin to nuclear capabilities. For Mr. Alexandr and Scale AI, the mission is clear: to provide the foundational data layer that accelerates AI development across all sectors, including national security. While Meta's significant investment marks a new chapter for Scale AI, potentially altering its client dynamics, Mr. Alexandr's core message about the paramount importance of data and the strategic implications of AI remains unchanged.

Started with only Rs 1700, IITian and tech titan Nikesh Arora rose to outearn Mark Zuckerberg and Sundar Pichai
Started with only Rs 1700, IITian and tech titan Nikesh Arora rose to outearn Mark Zuckerberg and Sundar Pichai

Time of India

time5 hours ago

  • Time of India

Started with only Rs 1700, IITian and tech titan Nikesh Arora rose to outearn Mark Zuckerberg and Sundar Pichai

When tech giants like Meta and Google made headlines for massive layoffs and changing leadership trends, one Indian-origin executive quietly outshone some of the biggest names in Silicon Valley. Nikesh Arora , the CEO of cybersecurity company Palo Alto Networks, earned more in 2023 than both Mark Zuckerberg and Sundar Pichai—an achievement that might surprise many unfamiliar with his journey. But behind that headline-making number lies a story of perseverance, rejection, and a steady climb from modest beginnings to one of the highest echelons in the global tech industry. When The Wall Street Journal released its 2023 rankings of the highest-paid CEOs, among the top earners was Nikesh Arora, the Indian-origin CEO of Palo Alto Networks, who secured the second spot with a total compensation of $151.43 million. His earnings significantly surpassed those of major tech leaders, including Meta's Mark Zuckerberg, who earned $24.40 million, and Google's Sundar Pichai, who received $8.8 million. In a detailed and candid conversation with Humans of Bombay, Arora opened up about the struggles and turning points that shaped his journey—from humble beginnings in Ghaziabad to leading one of the world's top cybersecurity firms. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like The Top 25 Most Beautiful Women In The World Articles Vally Humble Beginnings in India Arora's journey to the top of the tech industry began in Ghaziabad, Uttar Pradesh, where he was raised in a disciplined household shaped by his father's career in the Indian Air Force. His upbringing, marked by frequent relocations, instilled a deep sense of adaptability and integrity in him from an early age. After finishing school at The Air Force School, he pursued engineering at IIT-BHU. Despite financial limitations, Arora set his sights on the United States for further studies. With only $100 (around Rs 1700 in 1990) in hand, he applied to universities that waived application fees. Bostons' Northeastern University granted him a scholarship in 1990 and even offered him the chance to teach computer science—something he quickly had to learn to accept the offer. Career Struggles and Breakthrough After graduating, Arora faced a daunting phase—rejected over 400 times by various companies. He kept every rejection letter, using them as motivation. His breakthrough came in 1992 when he landed a role at Fidelity Investments. Starting from entry-level positions, he worked his way up to become Vice President at Fidelity Technologies. He later earned both an M.S. in Finance and a CFA certification, which significantly broadened his career options. Teaching a CFA course eventually connected him to an opportunity at Google. At Google and SoftBank Arora joined Google in 2004, a few months after its IPO. Over the next decade, he played a key role in growing its revenues from $2 billion to over $60 billion. Describing it as 'like being in a rocket ship,' Arora left in 2014 in search of a new challenge. That challenge came at SoftBank, where he served as President and COO. His time there brought significant learnings, including the importance of knowing when to walk away from underperforming investments—something he applied while choosing not to back WeWork. Arora eventually exited SoftBank in 2016 when CEO Masayoshi Son postponed his planned retirement. Leading Palo Alto Networks In 2018, after a sabbatical spent attempting (and failing) to improve at golf, Arora took over as CEO of Palo Alto Networks. At the time, the company was valued at $18 billion. Under his leadership, it has grown to over $100 billion, driven by a strategic push toward cloud security and artificial intelligence. Arora credits this success to early adoption of emerging technologies and a willingness to acquire or partner when internal development wasn't feasible. His focus on innovation has kept Palo Alto competitive in an increasingly complex cybersecurity landscape. On AI and India's Opportunity Arora has spoken about how scarcity in his youth shaped his resourcefulness and approach to leadership. He sees AI as a transformative force and believes India's strength lies in adapting global technologies to local contexts. According to him, real value in AI will come from localised data and domain-specific knowledge—areas where Indian companies have a natural advantage. Arora's story—marked by rejection, resilience, and reinvention—continues to resonate, especially in India. His rise shows that success doesn't always follow a linear path. As he told Humans of Bombay, 'Nobody likes rejection… But part of growing up in India is believing in destiny. It helps you rationalise failure. Everything happens for a reason.'

Kirti Ganorkar: Why the veteran insider is the right dose for Sun Pharma
Kirti Ganorkar: Why the veteran insider is the right dose for Sun Pharma

Time of India

time6 hours ago

  • Time of India

Kirti Ganorkar: Why the veteran insider is the right dose for Sun Pharma

Mumbai: For nearly thirty years, Kirti Ganorkar quietly stood at Sun Pharma as a rock, much like his astute boss Dilip Shanghvi , the founder of Sun Pharma. Steadfastly Shanghvi steered Sun Pharma from a small India-focused branded generic player to one that is rapidly emerging as a global specialty drugs company. From September 1, Kirti Ganorkar (58), a chemical engineer and a diehard cricket aficionado, will helm India's largest drugmaker as its managing director, while Shanghvi will continue in the role of executive chairman. In a June 13 statement, Sun Pharma said this marks the culmination of a structured and forward-looking succession planning process, underscoring the organisation's commitment to leadership continuity and strategic governance. For Ganorkar's elevation, the timing is crucial given the global scale of Sun Pharma's operations. It includes a growing and challenging business environment in the US, Europe and a range of emerging markets while keeping Sun Pharma at the top of the intensely competitive home market, India. For FY2025, Sun Pharma had sales of ₹52,041 crore, a 9% growth over the previous year, while its net profit stood at ₹11,984 crore, up 19%. Of which, Sun Pharma's global specialty products sales stood at $1.21 billion (₹10,334 crore), up 17.1%, and accounted for 19.7% of FY25 sales. Alone, Sun Pharma's India sales contribute over 32% of its global revenues. When Ganorkar made his move from German Remedies (acquired later by Zydus Lifesciences in 2001), a united entity for a group of German pharma companies and joined Sun Pharma in 1996 as an executive assistant to Shanghvi, the Indian pharma market was very different. Sun Pharma was at a fraction of its present size. The market was poised for a leap in sales of drugs for heart ailments, diabetes, neurology, and cancer, the segments that have been the primary focus for the company. Now, the dynamics have changed with almost every large Indian company showing prowess of deep reach and scientific expertise as they try to outclass others from in-licensing innovative products to launching their own. Industry experts, who follow Sun Pharma closely, say Ganorkar has a tough task ahead, but the established strength of the company comes as a big help. To succeed Dilip Shanghvi, known for his calculated yet bold moves, Ganorkar will need to combine all his experience. He has held diverse roles at Sun Pharma from business development, marketing, M&A, new product introductions, project management, to intellectual property litigation. An avid cricket follower, Ganorkar is the perfect all-rounder that Shanghvi has chosen. In the new innings, he must demonstrate the skills of MS Dhoni as a cool captain while showing the aggression of Virat Kohli. "Can he be good in the test match format and T20. That is the key," says a senior industry veteran, who was pleasantly surprised to see Ganorkar's new position. Economic Times WhatsApp channel )

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store